Ardelyx (ARDX)
(Delayed Data from NSDQ)
$6.45 USD
-0.29 (-4.30%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $6.45 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Brokerage Reports
0 items in cart
Ardelyx, Inc. [ARDX]
Reports for Purchase
Showing records 41 - 60 ( 172 total )
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
2Q23 Commercial Biotech Preview: Could 2Q23 Reporting Help Restart a Rally?
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
FDA Welcomes Tenapanor NDA Filing Back To Review Queue; Six-Month Review
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Don''t Miss The Forest For The Trees; Ibsrela On Track [1Q23 Highlights]
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Tenapanor NDA Submitted in Hyperphosphatemia (PDUFA Assignment To Come Later)
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
1Q23 Commercial Biotech Preview: Let''s Get It Started
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Ibsrela Script Data -- What Can We Take Away From The Launch So Far?
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Upgrading to Outperform: It''s an Ibsrela Story For Now, And That''s OK
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Biotechnology- 4Q22 Commercial Biotech Preview: A New Hope
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
With Tenapanor Progressing, Taking Up Our ARDX Target
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Christmas Comes Late - Appeal Granted for Tenapanor
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
"We Need More Time" Wasn''t At The Top Of Our Outcomes Scenarios
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
AdCom Follow Up: Odds May Have Gone Up, But Uncertainty Still Present
Provider: Wedbush Securities Inc.
Analyst: CHICO L